Hudson Bay Capital Management
LJPC

Hudson Bay Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Hudson Bay Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,000
Closed -$447K – 1070
2018
Q1 		$447K Sell
15,000
-15,000
-50% -$484K 0.01% 683
2017
Q4 		$965K Buy
30,000
+10,000
+50% +$327K 0.02% 400
2017
Q3 		$696K Buy
+20,000
New +$643K 0.02% 315

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Hudson Bay Capital Management's LJPC Position: Q2 2018 in Review

Hudson Bay Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2018, closing a stake of 15,000 shares — an estimated $447K sold.

Hudson Bay Capital Management first reported a position in LJPC in Q3 2017 and held it in 3 quarters. The position peaked at $965K in Q4 2017. 95 funds tracked by Wall St. Rank hold LJPC as of Q2 2018.

  • Hudson Bay Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2018 after selling out during the quarter.
  • Hudson Bay Capital Management sold 15,000 La Jolla Pharmaceutical Company shares in Q2 2018, an estimated $447K.
  • Hudson Bay Capital Management first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 3 quarters.
  • Hudson Bay Capital Management's La Jolla Pharmaceutical Company position peaked at $965K in Q4 2017.
  • 95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2018.

Based on Hudson Bay Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.